Thread: Stanford enrolling CRPS patients for LDN study
View Single Post
Old 07-04-2016, 09:55 PM
bluesfan bluesfan is offline
Member
  
Join Date: Jun 2014
Posts: 733
8 yr Member
bluesfan bluesfan is offline
Member
 
Join Date: Jun 2014
Posts: 733
8 yr Member
Default Stanford enrolling CRPS patients for LDN study
From the Stanford Medicine: Systems Neuroscience and Pain Lab:

"Low-Dose Naltrexone (LDN) for the Treatment of Complex Regional Pain Syndrome (CRPS) is currently enrolling participants."

Here's the link:
CRPS Treatment Study | Systems Neuroscience and Pain Lab | Stanford Medicine
bluesfan is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
BioBased (07-05-2016), catra121 (07-05-2016)